Capital International Sarl’s NovoCure NVCR Stock Holding History

Capital International Sarl’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-72,886	Closed	-$3.02M	–	229
2023 Q2	$3.02M	Sell	72,886 -11,813	-14%	-$734K	0.14%	148
2023 Q1	$5.09M	Buy	84,699 +20,758	+32%	+$1.66M	0.26%	113
2022 Q4	$4.69M	Buy	63,941 +9,108	+17%	+$685K	0.33%	94
2022 Q3	$4.17M	Sell	54,833 -5,969	-10%	-$466K	0.34%	94
2022 Q2	$4.23M	Buy	60,802 +9,221	+18%	+$695K	0.34%	97
2022 Q1	$4.27M	Buy	51,581 +5,237	+11%	+$386K	0.21%	127
2021 Q4	$3.48M	Buy	46,344 +34,792	+301%	+$3.49M	0.17%	140
2021 Q3	$1.34M	Sell	11,552 -1,523	-12%	-$230K	0.12%	156
2021 Q2	$2.9M	Buy	13,075 +2,378	+22%	+$463K	0.25%	109
2021 Q1	$1.41M	Buy	10,697 +540	+5%	+$85.4K	0.13%	148
2020 Q4	$1.76M	Buy	10,157 +448	+5%	+$61.3K	0.18%	121
2020 Q3	$1.08M	Buy	9,709 +2,101	+28%	+$168K	0.13%	135
2020 Q2	$451K	Buy	7,608 +717	+10%	+$47.2K	0.06%	180
2020 Q1	$464K	Sell	6,891 -909	-12%	-$71.8K	0.08%	148
2019 Q4	$657K	Buy	+7,800	New	+$630K	0.1%	138

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

Capital International Sarl's NVCR Position: Q3 2023 in Review

Capital International Sarl sold out of NovoCure (NVCR) in Q3 2023, closing a stake of 72,886 shares — an estimated $3.02M sold.

Capital International Sarl first reported a position in NVCR in Q4 2019 and held it in 15 quarters. The position peaked at $5.09M in Q1 2023. 226 funds tracked by Wall St. Rank hold NVCR as of Q3 2023.

Capital International Sarl reported no remaining NovoCure position as of Q3 2023 after selling out during the quarter.
Capital International Sarl sold 72,886 NovoCure shares in Q3 2023, an estimated $3.02M.
Capital International Sarl first reported a position in NovoCure in Q4 2019 and held it in 15 quarters.
Capital International Sarl's NovoCure position peaked at $5.09M in Q1 2023.
226 funds tracked by Wall St. Rank held NovoCure as of Q3 2023.

Based on Capital International Sarl's 13F filing for Q3 2023, filed 13 Nov 2023.